APPLICATION
ANDA063107
TYPE
ANDA
ORIGINAL APPROVAL
1991-08-23
LATEST ACTION
1994-04-25
ROUTE
TOPICAL
DOSAGE FORM
GEL
MARKETING STATUS
Discontinued
Products
EMGELDiscontinued
ERYTHROMYCIN 2% · GEL · TOPICAL
Approval history
1994-04-25Manufacturing (CMC) · Supplement 6AP
1994-04-04Manufacturing (CMC) · Supplement 7AP
1993-12-29Manufacturing (CMC) · Supplement 5AP
1993-04-09Manufacturing (CMC) · Supplement 4AP
1992-06-29Manufacturing (CMC) · Supplement 3AP
1992-04-29Manufacturing (CMC) · Supplement 2AP
1991-10-23Labeling · Supplement 1AP
1991-08-23OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.